HF
Therapeutic Areas
PCI Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PCI for Intratumoral Immunotherapy | Oncology (overcoming checkpoint inhibitor resistance) | Exploratory |
| PCI for Protein/Peptide Vaccines | Immunotherapy (immune response enhancement) | Phase 1 |
| PCI for Nucleic Acid Delivery | Dermatology | Preclinical |
| PCL for Viral Vector Manufacturing | Bioprocessing (AAV manufacturing) | Preclinical/Development |